Form 4 for LH Labcorp
Accepted 2024-05-02 00:00:00 ET · period of report 2024-04-30 · accession 0001127602-24-013820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-02 | 2024-04-30 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $201.37 | -4,496 | 46.3K | -9% | -$905.4K |
| D | 2024-05-02 | 2024-04-30 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +10.2K | 50.8K | +25% | — |
| D | 2024-05-02 | 2024-04-30 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | -10.2K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | F | D | 4,496 | $201.37 | 46,289 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-30 | M | A | 10,229 | — | 50,785 | D | — | — | (F1) Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. |
| 3 | Derivative | Performance Share Unit | 2024-04-30 | M | D | 10,229 | — | 0 | D | — · — to 2024-05-10 | 10,229 Common Stock | (F3) Amount includes an additional 1,059 Performance Shares resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea Holdings Inc. ("Fortrea"). (F1) Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. (F4) The Performance Shares vested in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and satisfaction of a performance condition related to the spin-off of Fortrea. |